JAK inhibitors and COVID-19 | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

This article has a correction. Please see:

Correction: JAK inhibitors and COVID-19 - April 01, 2023

Review

JAK inhibitors and COVID-19

Online download statistics by month:

Online download statistics by month: April 2022 to March 2024

	Abstract	Full	Pdf
Apr 2022	288	290	79
May 2022	505	541	230
Jun 2022	898	919	141
Jul 2022	636	648	152
Aug 2022	567	582	127
Sep 2022	535	545	104
Oct 2022	528	543	126
Nov 2022	383	386	126
Dec 2022	312	316	127
Jan 2023	318	333	165
Feb 2023	311	313	119
Mar 2023	248	249	119
Apr 2023	234	239	112
May 2023	214	216	94
Jun 2023	200	203	77
Jul 2023	235	239	94
Aug 2023	182	182	83
Sep 2023	160	162	83
Oct 2023	111	112	93
Nov 2023	186	191	119
Dec 2023	191	193	120
Jan 2024	138	138	110
Feb 2024	123	123	83
Mar 2024	231	232	190
Total	7734	7895	2873